The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?
By I. Chopra. Journal of Antimicrobial Chemotherapy, 2007
752 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Complementary and alternative medicine, Food Science
View Paper: https://www.semanticscholar.org/paper/eb086faa02f46948a824b672c4780741888d5f9e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Applied Microbiology and Biotechnology
In Complementary and alternative medicine
In Food Science
Citations in the corpus
- Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria (2010, background): “chloramphenicol, tetracycline, streptomycin and sulfonamides (Chopra 2007).”
- Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles (2016, background): “AgNPs-associated cytotoxicity, genotoxicity and inflammatory response in cells have raised concerns of their inadvertent exposure in humans (Chopra, 2007).”
- "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. (2011, background): “Using silver to treat bacterial infections became unpopular after penicillin was introduced in the 1940s [66].”
- Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. (2008, background): “Bacterial resistance to silver has been a concern with the significant increase in the usage of silver-containing products to manage infections.(28,29) Several studies suggest that it is secondary to a plasmid-related increase in silver binding to periplasmic membrane proteins and in silver efflux t”
- Enhanced antibacterial activity of bifunctional Fe3O4-Ag core-shell nanostructures (2009, background): “Silver is a recognized cause of argyrosis and argyria [7, 8], and clinical toxicity of silver to mammiferous cells has also been reported [9–11].”
- Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications (2013, background): “Basing on their results, some authors state that in clinical isolates the prevalence of silver resistant strains is low [117,118].”
- Alternative Antimicrobial Approach: Nano-Antimicrobial Materials (2015, background): “But today, with the emergence of antibiotic-resistant strains, it has gained new, yet controversial, interest [29].”
- Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans” (2018, background): “Concerns regarding the cytotoxicity and genotoxicity of AgNPs have been raised (Chopra, 2007) but various authors have conducted clinical trials based on AgNPs and no important clinical alterations have been detected (Munger et al., 2014a,b; Smock et al., 2014).”